News & Events about Morphic Holding Inc.
Globe Newswire
4 months ago
WALTHAM, Mass., May 05, 2023 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Morphic), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, today announced the closing of an underwritten public offering of 6,133,334 shares of its ...
Globe Newswire
4 months ago
WALTHAM, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, today announced the pricing of an underwritten public offering of 5,333,334 shares of ...
Ticker Report
5 months ago
Morphic Holding, Inc. (NASDAQ:MORF Get Rating) President Bruce Rogers sold 10,000 shares of Morphic stock in a transaction on Monday, April 17th. The shares were sold at an average price of $40.35, for a total transaction of $403,500.00. Following the completion of the sale, the president ...
InvestorPlace
5 months ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.
The post 7 Biotech Stocks to Buy for 100% Returns appeared first on InvestorPlace...
Globe Newswire
6 months ago
WALTHAM, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic(Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that its management team will participate a panel discussion focused on ...